touchCARDIO touchCARDIO
Arrhythmia, Atrial Fibrillation
Read Time: 2 mins

42/RETRO-map: A novel algorithm to map persistent atrial fibrillation shows a reduction in wavefront collision following circumferential pulmonary vein isolation

Copy Link
Published Online: Oct 9th 2012 European Journal of Arrhythmia & Electrophysiology. 2022;8(Suppl. 1):abstr42
Authors: I Kanella (Presenting Author) – Imperial College London, London; C Coyle – Hammersmith Hospital, London; I Mann – Hammersmith Hospital, London; E Lim – Hammersmith Hospital, London; M Fudge – Hammersmith Hospital, London; N Qureshi – Hammersmith Hospital, London; M Koa-Wing – Hammersmith Hospital, London; Z Whinnett – Hammersmith Hospital, London; P Boon Lim – Hammersmith Hospital, London; F Siong Ng – Hammersmith Hospital, London; NS Peters – Hammersmith Hospital, London; DP Francis – Hammersmith Hospital, London; N Linton – Hammersmith Hospital, London; P Kanagaratnam – Hammersmith Hospital, London
Quick Links:
Article
Article Information
Article:

Background: Determining the mechanisms driving atrial fibrillation (AF) during clinical procedures remains challenging. RETRO-map enables the analysis of intracardiac electrograms (EGM) to display activation maps during AF. We used RETRO-map to study the impact of circumferential pulmonary vein ablation (CPVA) on activation patterns in persistent AF.

Methods: Patients undergoing CPVA for persistent AF using the Precision™ 3D navigation system were recruited. An AFocusII catheter was positioned on the left atrial endocardium and 30 s of AF was recorded at multiple sites prior to CPVA. Following CPVA, this was repeated at the same locations. The data were exported to a custom-written MatLab program and analysed. The RETRO-mapping algorithm produced continuous activation maps and screened 2 ms time windows for evidence of focal activation, planar waves and wavefront collisions. These automated categorisations were manually validated and compared between pre/post CPVA using a standard T-test.

Results: Ten patients with a mean age of 61.3 ± 12.1 years (80% male) were recruited. The mean duration of persistent AF was 23 (9–51) months and the mean left atrial diameter was 45.0 ± 4.7 mm. Overall, 115 data segments were recorded from 61 different locations in these 10 patients. Using 3 s of data from each segment, 53 focal waves, 652 planar waves and 168 collisions were identified and manually validated. RETRO-map was highly effective at identifying focal waves and collisions, achieving 100% correlation with manual validation within the 2 ms time windows. For planar waves, the RETRO-map planar categorisation had to occur in 12 consecutive time windows (≥24 ms duration) to achieve an 80.3% correlation with manual validation. Comparing pre- and post-PVI recordings, the mean number of collisions significantly reduced (21.3 × 10-6 collisions/mm2/s/patient pre-PVI to 13.9 × 10-6 collisions/mm2/s/patient post-PVI; p=0.006). PVI decreased the number of focal activations (1.86 × 10-6 focals/mm2/s/patient pre-PVI to 1.17 × 10-6 focals/mm2/s/patient post-PVI; p=0.287), and it had no effect on the manually validated planar waves (16.0 × 10-6 planars/mm2/s/patient pre-PVI vs 16.1 × 10-6 planars/mm2/s/patient post-PVI).

Conclusion: RETRO-mapping showed that circumferential pulmonary vein ablation caused a reduction in wavefront collision. With larger series and additional ablation sets, RETRO-mapping may be able to determine the mechanisms maintaining AF.

Further Resources

Share this Article
Related Content In Atrial Fibrillation
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72